Systemic targeting of aberrant neovascular tufts using trehalose-dendrimer nanocarriers for the treatment of proliferative retinopathies.
Sign Up to like & getrecommendations! Published in 2026 at "Theranostics"
DOI: 10.7150/thno.120357
Abstract: Rationale: Proliferative retinopathies are the leading causes of blindness worldwide. Current treatment paradigms rely heavily on intravitreal injections of anti-vascular endothelial growth factor A (anti-VEGFA) agents, which, despite their efficacy, are associated with ocular complications… read more here.
Keywords: treatment; aberrant neovascular; tre axitinib; neovascular tufts ... See more keywords